Acute Effects of Upper Arm Tissue Flossing on Upper Extremity Performance and Power (AUERTF)

June 22, 2026 updated by: esedullah akaras, Erzurum Technical University

Acute Effects of Upper Arm Tissue Flossing on Closed-Chain Upper Extremity Stability and Explosive Upper-Body Power: A Randomized Sham-Controlled Trial

This randomized sham-controlled trial investigates the acute effects of upper arm tissue flossing on upper extremity performance and power in healthy adults. Tissue flossing is a compression-based intervention that involves wrapping an elastic band around a limb for a short period while performing movement exercises.

Twenty-eight healthy participants are randomly assigned to either an active tissue flossing group or a sham flossing group. The intervention is applied to the dominant upper arm. Upper extremity performance is assessed before the intervention and at 2 and 15 minutes after the intervention using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) and the Seated Medicine Ball Throw (SMBT).

The study aims to determine whether a single session of upper arm tissue flossing can produce immediate improvements in upper extremity stability, functional performance, and explosive power compared with a sham intervention

Study Overview

Detailed Description

Tissue flossing is a relatively new technique used in sports and rehabilitation settings. It involves applying a specialized elastic compression band around a limb while the individual performs active movements. Proposed mechanisms include temporary vascular occlusion followed by reperfusion, alterations in neuromuscular function, and changes in fascial tissue mobility. Although tissue flossing has been investigated for lower extremity performance and range of motion outcomes, evidence regarding its effects on upper extremity performance remains limited.

The purpose of this study is to examine the acute effects of upper arm tissue flossing on upper extremity functional performance and power in healthy adults. This study is designed as a randomized, sham-controlled, parallel-group trial.

A total of 28 healthy volunteers are randomly allocated to either an active tissue flossing group or a sham flossing group. Participants in the active intervention group receive tissue flossing applied to the dominant upper arm using a standardized compression protocol. Participants in the sham group receive a loosely applied band that does not provide therapeutic compression. During band application, participants perform standardized upper extremity movements.

Outcome measurements are obtained at baseline, 2 minutes after intervention, and 15 minutes after intervention. Upper extremity functional performance is assessed using the Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST). Explosive upper-body power is assessed using the Seated Medicine Ball Throw (SMBT).

The primary objective is to determine whether upper arm tissue flossing produces immediate improvements in upper extremity stability and performance compared with a sham intervention. Findings from this study may contribute to understanding the potential role of tissue flossing as a practical strategy for enhancing upper extremity performance in healthy individuals and physically active populations.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Age 18-35 years.
  2. Absence of current upper-extremity pain or dysfunction.
  3. Ability to safely assume a full push-up position and perform a two-handed seated chest pass.

Exclusion Criteria:

  1. History of upper-extremity surgery.
  2. Acute musculoskeletal injury within the preceding 6 months.
  3. Known vascular disease, coagulation or clotting disorders, uncontrolled hypertension, or any other contraindication to short-term circumferential limb compression.
  4. Confirmed latex allergy, given that the floss band used in this study was latex-based.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Active Flossing Group
Participants (n=14) receive a structured circumferential compression protocol on their dominant upper arm using an elastic latex floss band stretched to moderate tension, followed by a brief active movement sequence.
The floss band is applied to the participant's dominant upper arm by a licensed physiotherapist. Wrapping proceeds in a distal-to-proximal direction with approximately 50% overlap between layers, terminating just distal to the axilla. The band is stretched to a standardized elongation between 50% and 70% of its maximal length to generate moderate circumferential compression. Once wrapped, the participant performs a standardized 2-minute low-to-moderate intensity active movement sequence consisting of repeated elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination. The band is fully removed immediately following the 2-minute movement block
The floss band is applied to the participant's dominant upper arm by the same physiotherapist, maintaining identical therapist contact time, limb positioning, and overall session duration as the active group. However, the band is applied with less than 10% elongation, creating a loosely snug contact fit insufficient to generate meaningful circumferential compression or local vascular occlusion. Once wrapped, the participant performs the exact same 2-minute low-to-moderate intensity active movement sequence (elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination) before the band is fully removed.
Sham Comparator: Sham Flossing
Participants (n=14) receive a loose, minimal-tension wrap on their dominant upper arm using the same floss band type, performing the identical active movement sequence to isolate the effects of compression intensity
The floss band is applied to the participant's dominant upper arm by a licensed physiotherapist. Wrapping proceeds in a distal-to-proximal direction with approximately 50% overlap between layers, terminating just distal to the axilla. The band is stretched to a standardized elongation between 50% and 70% of its maximal length to generate moderate circumferential compression. Once wrapped, the participant performs a standardized 2-minute low-to-moderate intensity active movement sequence consisting of repeated elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination. The band is fully removed immediately following the 2-minute movement block
The floss band is applied to the participant's dominant upper arm by the same physiotherapist, maintaining identical therapist contact time, limb positioning, and overall session duration as the active group. However, the band is applied with less than 10% elongation, creating a loosely snug contact fit insufficient to generate meaningful circumferential compression or local vascular occlusion. Once wrapped, the participant performs the exact same 2-minute low-to-moderate intensity active movement sequence (elbow flexion/extension, shoulder flexion/extension, and forearm pronation/supination) before the band is fully removed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Seated Medicine Ball Throw (SMBT) distance
Time Frame: Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal
Upper-extremity explosive power was assessed using the seated medicine ball throw. Participants were seated upright with back support and projected a 2-kg medicine ball horizontally as far as possible in a chest-pass motion. Throw distance was measured from a fixed start line to the point of initial ball contact.
Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal
Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) score
Time Frame: Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal.
Upper-extremity closed-chain stability was assessed using the CKCUEST. Participants assumed a full push-up (high-plank) position with hands placed on two parallel strips of tape positioned 91.4 cm apart. Participants alternately touched the opposite hand as rapidly as possible for 15 seconds. The metric recorded is the total number of completed hand touches within the 15-second interval.
Measured at three time points: Baseline (Pre-intervention), 2 minutes post-removal, and 15 minutes post-removal.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Esedullah AKARAS, Dr., Erzurum Technical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2026

Primary Completion (Actual)

April 15, 2026

Study Completion (Actual)

May 3, 2026

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

June 22, 2026

First Posted (Actual)

June 26, 2026

Study Record Updates

Last Update Posted (Actual)

June 26, 2026

Last Update Submitted That Met QC Criteria

June 22, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ETU-2026-TF-UEP-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

our protocol explicitly states that the datasets generated and analyzed during the study are openly available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Active Myofascial Compression

Subscribe